The N-terminal tails of the four core histones are subject to several types of covalent post-translational modifications that have specific roles in regulating chromatin structure and function. Here we present an extensive analysis of the core histone modifications occurring through the cell cycle. Our MS experiments characterized the modification patterns of histones from HeLa cells arrested in phase G 1 , S, and G 2 /M. For all core histones, the modifications in the G 1 and S phases were largely identical but drastically different during mitosis. Modification changes between S and G 2 /M phases were quantified using the SILAC (stable isotope labeling by amino acids in cell culture) approach. Most striking was the mitotic phosphorylation on histone H3 and H4, whereas phosphorylation on H2A was constant during the cell cycle. A loss of acetylation was observed on all histones in G 2 /M-arrested cells. The pattern of cycle-dependent methylation was more complex: during G 2 /M, H3 Lys 27 and Lys
The cell cycle constitutes a series of interrelated processes that includes accurate duplication of the vast amount of DNA in the chromosome and segregation of the copies into two genetically identical daughter cells. These events define the two major phases of the cell cycle: DNA replication, which occurs during synthesis (S) phase, and chromosome segregation followed by cell division, which take place during mitosis (M phase). The two gap phases, G 1 and G 2 , before S and M phases, allow cells to grow. The fundamental unit of eukaryotic chromatin is the nucleosome core particle, which consists of DNA in close association with an octamer of the core histone proteins H2A, H2B, H3, and H4. The N-terminal tails of each of the four core histones are subject to several types of covalent modification, including acetylation and methylation of lysines, methylation of arginines, and phosphorylation of serines and threonines (1) . The reversible histone modifications that affect the charge density of the flexible N-terminal and C-terminal domains or introduce bulky ubiquitin moieties have considerable potential to modulate histone/DNA interactions in chromatin. Histone modifications are also able to affect binding interactions with other proteins that may, in turn, alter the higher order structure of chromatin (2, 3) .
Conceptually it may be useful to distinguish between modifications that occur locally at regions of chromosomes and at the entire set of chromosomes (4) . Thus, acetylation and/or lysine as well as arginine methylation occurs locally on precisely defined sites such as a nucleosome in the vicinity of a transcription factor binding site. In fact, the activity of the transcription factor-recruited enzymes determines the modification patterns (5) . Experimentally definition of modifications at single nucleosomes is so far only possible by chromosome immunoprecipitation. At a higher level of chromatin organization, modifications such as methylation of H3 at Lys 9 are instrumental in silencing entire regions of chromosomes to form heterochromatin (6) . Finally modifications that occur during mitosis affect a large proportion of nucleosomes on all chromosomes (7) . Phosphorylation of histone proteins is involved in the transition from interphase to mitotic chromatin. However, definitive roles of phosphorylation in this process have not yet been elucidated (8, 9 ). An increase in histone H3 Ser 10 phosphorylation is a well known hallmark for mitosis and meiosis in various eukaryotic organisms (10) . Recent reports have shown that H3 is also phosphorylated at Ser28, Thr11, Thr3, and H3.3 Ser 31 during mitosis (11) (12) (13) (14) . For histones H4 and H2A, hyperphosphorylation was detected at their respective Ser 1 residues during mitosis in worm, fly, and mammalian cells (15) . For histone acetylation, one of the better understood histone modifications, it is now generally accepted that hyperacetylated histones are mostly associated with activated genomic regions, whereas deacetylation mainly results in repression and silencing (16, 17) . In contrast, histone methylation appears to have multiple effects on chromatin function (18 -20) . Methylation of H3 on Lys 9 , for example, is largely associated with silencing and repression in many species (6, 21) , and methylation of H3 Lys 27 is suggested to be involved in transcriptional repression (22, 23) . However, methylation of H3 Lys 4 , Lys 36 , and Lys 79 were linked to actively transcribed genes (24 -26) . One challenge is to define the molecular events that link histone modifications with specific biological outcomes, such as transcriptional activation or repression.
Most of the studies describing histone modifications rely on the use of modification-specific antibodies to identify and monitor changes in modifications (e.g. Western blot, chromatin immunoprecipitation, and immunofluorescence). However, the use of these immunological reagents has limitations. First, it is not trivial to define the specificity of these antibodies (27, 28) . Second, the influence of multiple modifications on a single histone is likely to impact the recognition by modification-specific antibodies. Finally except for a few antibodies, only one modification site is probed for at a time. Therefore, almost no information can be obtained in this way on the simultaneous presence of multiple modifications on one histone protein. Indeed it has been shown that some modifications have synergistic effects (29) . In contrast, MS is a powerful technique that allows the identification of single post-translational modifications as well as multiple modifications on the same peptide (30 -33) . MS should hence be suitable for characterizing the modification patterns of histones that occur at a specific stage of the cell cycle. Combined with isotope labeling, mass spectrometry also allows quantitation of changes in modification occurring between different stages. In this study, we investigated post-translational modifications of the four human core histones of HeLa cells arrested in G 1 , S, and G 2 /M phases. In our strategy, histones were separated by HPLC and then digested with proteases (Glu-C, Arg-C, or trypsin) to produce fragments of suitable length for analysis by nano-ESI MS and MS/MS. For quantifying changes of modifications between S and G 2 /M phases we applied the technique of stable isotope labeling by amino acids in cell culture (SILAC) 1 (34, 35) .
EXPERIMENTAL PROCEDURES
Extraction of Histones-HeLa cells were cultured in Dulbecco's modified Eagle's medium containing 10% dialyzed FCS and 100 IU of penicillin/streptomycin to reach 40 -60% confluence. For G 1 phase synchronization, aphidicolin (Sigma-Aldrich) was added to the medium to a final concentration of 1 g/ml and incubated for 24 h at 37°C before harvesting the cells (36, 37) . For S phase synchronization, cells were treated with aphidicolin as for G 1 synchronization, and after 24 h incubation normal growth medium was added for an additional 6 h at 37°C before harvesting the cells. For G 2 /M phase synchronization, nocodazole (Sigma-Aldrich) was added to the medium to a final concentration of 50 ng/ml and incubated for 24 h at 37°C before harvesting the cells (38) . HeLa cells were cultured in two 150-mm plates to reach a total of ϳ4 ϫ 10 7 cells for each condition. To collect cells, the medium was removed from the plates, cells were washed twice with PBS, 10 ml of 10% trichloroacetic acid were added to the plate, and the cells were scratched off and centrifuged at 2000 ϫ g for 8 min. For all three conditions, the cell pellet was suspended in the extraction buffer (80 mM NaCl, 20 mM EDTA, 1% Triton, 1 mM NaF, 10 mM ␤-glycerophosphate, 1 mM sodium vanadate, 45 mM sodium butyrate, protease inhibitors) and centrifuged at 2000 ϫ g for 8 min. For preparing histones (39) , the pellets were resuspended in 900 l of 0.2 M H 2 SO 4 (2 h at 4°C). After centrifugation at 16,100 ϫ g, supernatants were precipitated by trichloroacetic acid (25% final concentration). The pellet was washed with 50 mM HCl in acetone, then with acetone, and subsequently dissolved in ␤-mercaptoethanol (0.1%) in water. For each condition, ϳ50 g of histone protein were obtained (Bio-Rad protein assay).
HPLC Separation and Digestion of Histones-The histone proteins were separated using reversed-phase HLPC (Agilent 1100 series, Agilent, Palo Alto, CA) (40) . After elution from HPLC, 85% of histones were collected, and 15% were analyzed by mass spectrometry. Preparative HPLC fractions containing individual histones were pooled according to UV and MS chromatograms, dried (SpeedVac SC 110, Savant Instruments, Farmingdale, NY), and dissolved in 5-10 l of 25 mM NH 4 HCO 3 or 100 mM Tris-HCl, pH 8. The histones H2A and H2B were digested with endoproteinase Glu-C (sequence grade, Roche Diagnostics) in 25 mM NH 4 HCO 3 at an enzyme ratio of 1:20 at 25°C for 1-2 h. The histones H4 and H3 were digested either with endoproteinase Glu-C (sequence grade, Roche Diagnostics) in 25 mM NH 4 HCO 3 at an enzyme ratio of 1:20 at 25°C for 1-2 h or with endoproteinase Arg-C (sequence grade, Roche Diagnostics) at an enzyme ration of 1:100 at 37°C for 1-2 h in 100 mM Tris-HCl, pH 8. The reaction was stopped by adding formic acid to a final concentration of 0.1%. For desalting, 5-10 l of peptide mixtures were absorbed on a POROS R3 column, washed with 0.2% formic acid, and desorbed sequentially with 2 l of 10, 20, 30, and 50% methanol in 0.2% formic acid. Peptides H3-(1-19), H3-(9 -17), H3- (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) , and H2B-(1-35) were eluted at 10% methanol. Peptides H2A-(1-41) (for the first and second HPLC peaks) and peptides H3-(73-83) were eluted at 50% methanol after 10, 20, and 30% step elutions. Peptides H4-(4 -17) and H4- (20 -35) were directly eluted at 50% methanol, and peptides H4-(1-24) and H4- (18 -26) Then the samples were mixed in equal amounts, and the protein mixtures were fractionated and analyzed by LC-MS. After collecting histone fractions, the proteins were digested with endoproteinase Arg-C as described above.
To quantitate changes in post-translational modifications occurring in G 2 /M phase compared with S phase (set to 1), the ratio R* was calculated as follows. The intensities of the monoisotopic peaks of the labeled (G 2 /M) and the nonlabeled (S) peptides were considered for all calculations. First, the 13 C atom enrichment ( ϭ 0.99 for the arginine used) was taken into consideration, and the probability for six 13 2 ) (see supplemental data). Finally a correction factor was applied to the heavy and light ratios to correct for deviations from the theoretical 1:1 mixing of labeled and nonlabeled samples. This correction factor was calculated using the intensities of the monoisotopic peaks corresponding to [ 12 C 6 ]Arg (x) and [ 13 C 6 ]Arg (y) peptides known to be devoid of modifications, Corr ϭ 1/( 6 ⌬(x/y ϩ ⌬ Ϫ 1). The corrected ratios were given by R* ϭ R/Corr.
Mass Spectrometry-LC-MS of intact histones was conducted on an HPLC system (Agilent 1100 series) coupled to an LCQ electrospray ion trap mass spectrometer (LCQ, Thermo Finnigan, San Jose, CA). For optimal ESI conditions, spray voltage was set to 4000 V, capillary temperature was 200°C, capillary voltage was set to 8 V, and the tube lens was set to 16 V. The instrument was scanning between 200 and 2000 Da. We estimated a mass accuracy of 1-2 Da for intact proteins. The molecular masses of the histones were determined after deconvolution of the multiply charged ion series (Bioworks software, Thermo Finnigan). Interpretation of MS spectra was done manually by comparing measured masses to calculated masses of histone sequences derived from Swiss-Prot.
For peptide mass fingerprints, ESI mass spectra were recorded on a QStar Pulsar hybrid quadrupole time-of-flight mass spectrometer equipped with a nanospray ion source (Applied Biosystems, Foster City, CA). The needles (Proxeon, Odense, Denmark) containing the peptide mixtures were adjusted in front of the orifice, and the spray voltage was set between 900 and 1300 V. MS spectra were acquired by scanning over m/z range 200 -2000. Mass accuracy of at least 0.02 Da was achieved with external calibration. Parent ions were selected for CID with a mass window of Ϯ0.5 Da. Interpretation of MS and MS/MS spectra was done manually by comparing the measured peptide and fragment masses with those calculated according to histone sequences (Supplemental Table I ).
RESULTS

General Strategy of MS Analysis of Histones from
Cell Cycle-arrested Cells-For obtaining cell populations arrested at defined points in the cell cycle, HeLa cells, which are widely used for such studies, were exposed to aphidicolin, an inhibitor of DNA polymerase, to enrich for cells at the G 1 /S boundary (36, 37) . Release from the aphidicolin block for 7 h yielded a population rich in S phase cells. Nocodazole, a microtubule depolymerizing agent, results in cells accumulating at the G 2 /M boundary (38) . Histones from these three cell preparations were resolved by reversed-phase chromatography into fractions that contained histones H2A, H2B, H3, and H4 (Supplemental Fig. 1 ) (40) . 15% of the histones eluting from HPLC were analyzed directly by MS, and 85% were digested with specific proteases. The peptide mixtures were subsequently analyzed by MS and MS/MS. This strategy allowed us to characterize the post-translational modifications present on all histone variants. Analysis by LC-MS of intact histones isolated from the different phases gave us indications of changes in post-translational modifications (Supplemental Figs. 2-5 ). However, analysis of peptides generated after histone digestion was necessary to pinpoint changes at individual amino acid positions. To achieve full sequence coverage for all histones, different proteases were used for the digestions. Endoproteinase Glu-C and Arg-C were used for H2A, Glu-C and trypsin were used for H2B (40) , and Arg-C and Glu-C were used for H3 and H4 (Supplemental Table I ). After digestion, the peptide mixtures were analyzed by nano-ESI MS. The nanospray MS allowed us to optimize the quality of MS/MS spectra in particular for multiply modified large peptides. This optimization would have been difficult to achieve with true HPLC separation coupled on line to the mass spectrometer where typically acquisition of MS/MS spectra is performed in seconds rather than minutes for manual nanospray MS. Full sequence coverage was achieved for H2A, H2B, and H4, and almost 99% sequence coverage was reached for H3 and its variants. The post-translational modifications of histones H2A, H2B, H3, and H4 and their variants from HeLa cells were identified by MS and MS/MS (Table I) . For histones H4 and H3, results are summarized in Tables II,  III , and IV.
To confirm the modification changes during the cell cycle, a quantitative mass spectrometric analysis using a SILAC strategy was used (35) . The labeled amino acids, in this case arginine, were incorporated into all proteins as they were synthesized (34) . Cells grew normally in the presence of labeled medium, and incorporation was nearly complete after three days (93% of incorporation). The changes in post-translational modifications occurring in G 2 /M phase compared with S phase were calculated as ratios of the intensities of the monoisotopic peaks of the labeled (G 2 /M) versus nonlabeled (S) peptides. These ratios were calculated taking into account the incorporation of isotopic labeled arginine into proteins (here 93%) and the incorporation of 13 C into arginine (here 99%). Furthermore these ratios were then corrected for variation from the theoretical 1:1 mixing of labeled and nonlabeled samples by using the monoisotopic peaks of the labeled (G 2 /M) versus nonlabeled (S) non-modified peptides. The SILAC experiments were done twice, and each biological experiment was analyzed by MS several times. MS quantitation was only performed for histones H3 and H4. For histones H2A and H2B, MS quantitation was difficult to perform due to the low ion intensities of modified peptides, the overlapping of the non-labeled and isotopically labeled peptide ions, and the presence of numerous variants.
We focused our MS and MS/MS analysis on the histone peptides in which we detected modifications by MS; as expected the majority of them were located on the N-terminal tails. In the following, we give details on our findings for each of the core histones.
Acetylation on Histones H2A and H2B Was Reduced in G 2 /M Phase-In HeLa cells, the same variants of histones H2A and H2B were found as in Jurkat cells (Table I and . Inspection of the mass spectra of intact H2A and H2B histones for G 1 , S, and G 2 /M phases indicated a decrease in acetylation for H2BQ/Q5QNW6 and H2AO between S and G 2 /M phases. However, for the major H2AC and H2BA histone variants, it was difficult to observe changes in acetylation during the cell cycle due to the presence of various variants with close molecular masses. Therefore, peptides generated after histone digestion were analyzed.
Thus, the major H2A variants H2AO (first HPLC peak) and H2AC (second HPLC peak) were acetylated on Lys 5 and phosphorylated on Ser 1 ( Fig. 1, A and B, and Table I ). In addition, acetylation on Lys 5 was confirmed for both H2A variants by MS/MS analysis of Arg-C peptides 1-11 (Supplemental Figs. 14 and 20). The ion intensities corresponding to modified peptides 1-41 were low compared with the nonmodified peptides. Still comparison of the ion intensities of these peptides for G 1 , S, and G 2 /M phases indicated absence of acetylation on Lys 5 in the G 2 /M phase, whereas phosphorylation on Ser 1 was apparently not changed. This observation was confirmed for histone H2A (second HPLC peak) by analyzing ions corresponding to peptide 1-41 with a different charge state (Supplemental Fig. 6 ). For histone H2B, most of the variants in the G 1 experiment were found to be monoacetylated and diacetylated for the most intense variant, H2BA ( Fig. 1C and Table I ). In all three analyses, the ion intensities of acetylated peptides were decreased in S phase, and most of these ions were absent in G 2 /M phase. For the monoacetylated H2BJ/N and H2BA variants, MS/MS analysis of the corresponding peptides localized acetylation on Lys 12 , Lys 15 , and Lys 20 (Supplemental Figs. 16 and 18 and Ref. 40 ). In conclusion, these results for histone H2A and H2B variants indicated a relative decrease of acetylation in the mitotic phase, whereas phosphorylation on H2A remained unchanged. All MS/MS spectra of peptides listed in Table I are shown in the supplemental data.
Complex Pattern of Modification Changes on Histone H4 during the Cell Cycle-The molecular masses of histone H4 were determined after deconvolution of multiply charged ion series. Inspection of H4 mass spectra indicated changes in methylation and acetylation between G 1 , S, and G 2 /M phases (Supplemental Fig. 5 ). Analysis of peptides generated after histone digestion was then performed to confirm these changes.
Indeed the ion intensities corresponding to mono-and diacetylated peptides 4 -17 were intense compared with the non-acetylated peptide ( Fig. 2A) . Comparison of the ion intensities of these peptides derived from G 1 -, S-, and G 2 /Marrested cells showed a relative decrease in acetylation in G 2 /M phase, such as for histones H2A and H2B. In addition, MS quantitation by SILAC confirmed this decrease in acetylation in G 2 /M phase for mono-and diacetylated peptides (10 and 50% reduction, respectively; see Fig. 2B ). The non-modified and triacetylated peptides 4 -17 were difficult to quantitate due to their low intensities. Analysis by MS/MS of the 20 , and the ion intensities corresponding to the mono-and dimethylated peptides 20 -35 were changing during the cell cycle (Supplemental Fig. 7) . In contrast to histone H4 acetylation, MS quantitation revealed an increase of methylated peptides 20 -35 in G 2 /M phase compared with S phase (150% monomethylation and 40% dimethylation; see Fig. 2C ). Phosphorylation on Ser 1 was investigated by MS analysis of Glu-C peptide 1-24 (Fig.  3) . The ions at m/z [525.91] 5ϩ and m/z [534.31] 5ϩ were prominent in G 2 /M phase and barely detected in G 1 and S. These ions were identified as peptides containing phosphorylation on Ser 1 in addition to the methylation and acetylation already described for peptides 4 -17 and 20 -35 ( Fig. 3 and Table II ). All MS/MS spectra of peptides listed in Table II peaks of the histone HPLC chromatogram were attributed to full intact H3 protein modified with several post-translational modifications (Supplemental Fig. 1) (40) . However, the change in post-translational modifications during the cell cycle was difficult to observe from mass spectra of intact histone H3 and its variants due to the complexity of the spectra. Also assignment of the variants was only possible by peptide mapping of the three HPLC peaks. Analysis by MS/MS identified the specific Arg-C peptides 84 -116 from H3. 18 and/or Lys 23 on all three variants. Ions corresponding to mono-and diacetylated peptides were intense in the spectrum, whereas ions corresponding to nonmodified peptides were detected by MS/MS but difficult to discriminate from contaminating ions in MS experiments (Table III and Supplemental Fig. 8 ). Based on the MS analysis, slight intensity changes for the ions corresponding to the diacetylated peptides were observed between the three (Fig. 4, A Fig. 9, A and B) . Unexpectedly the endoproteinase Arg-C cleaved after Lys 36 to generate peptide 27-36. MS/MS analysis of ions corresponding to modified peptides 9 -17 identified the presence of contaminating ions corresponding to modified peptides 27-36. The modified peptides 9 -17 and 27-36 had identical masses for the H3.1 and H3.2 variants, whereas for the H3.3 variant, mass shifts of 2 Da were observed for peptides 27-36 due to variation on H3.3 at residue 31 (Supplemental Fig. 9B ). For peptide 27-36, mono-, di-, and trimethylations were observed on Lys 27 and Lys 36 for the three cell cycle phases. These modifications were further described in the analysis of peptide 27-40. For H3 variants in the three cell cycle phases, mono-and dimethylations were identified on Lys 9 and Lys 14 (Table III) . However, trimethylation and acetylation were preferentially detected on Lys 9 and Lys 14 , respectively (Table III) . MS/MS analysis with high mass accuracy allowed us to differentiate between acetyllysine and trimethyllysine. In this study, we used an electrospray ionization tandem MS instrument (hybrid quadrupole time-of-flight mass spectrometer) with a mass resolution around 10,000 (full width at half-maximum) and a mass accuracy of at least 0.02 Da with external calibration. To differentiate between acetylation (mass increment, 42.0106 Da) and trimethylation (mass increment, 42.0470 Da) of a modified lysine, we compared measured and calculated mass differences (in ppm) between two specific fragment ions from MS/MS spectra of the modified peptides 9 -17 (Supplemental Tables II, III, and IV) .
Specifically for the G 2 /M phase, five additional peptide ions were detected and identified as phosphorylated peptides 9 -17 for each of the H3 variants ( Fig. 5 and Supplemental Fig.  9, A and B) . Also the presence of contaminating ions corresponding to phosphorylated modified peptides 27-36 was detected. For H3.1 and H3.2, MS/MS analysis of peptides 9 -17 identified phosphorylation on Ser 10 in addition to methylation of Lys 9 and methylation or acetylation of Lys 14 (Table  III) . Also due to the low amount of H3.3 variant protein, MS/MS analysis of the corresponding 9 -17 phosphopeptides in G 2 /M phase was difficult to perform. SILAC quantitations were not performed for the ions corresponding to modified peptides 9 -17 due to contamination by peptides 27-36. All MS/MS spectra of peptides 9 -17 listed in Table III are shown in the supplemental data.
Histone H3: Ser 10 and Thr 3 Phosphorylation Was Only Detected in G 2 /M-To cover the first eight amino acids of H3, digestion with endoproteinase Glu-C was necessary. Unexpectedly this protease cleaved histone H3 after Gln residues and generated peptides 1-19. Analysis of peptides [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] could only be reported for the H3.2 variant (Fig. 6A and Table  III ). The modification patterns of peptide 1-19 were very similar for G 1 and S phases, consisting of four peptide ions with mass increments corresponding to methylation (14 Da) and/or acetylation (42 Da). In G 2 /M, we observed peptide ions with mass increments corresponding to one or two phosphorylations in addition to methylation and/or acetylation. The MS/MS analyses of these modified peptides were very complicated due to the presence of several modifications on peptide 1-19 (Lys 9 , Ser 10 , Lys 14 , and Lys 18 ). We concentrated our analysis on the first residues of peptide 1-19 because sequence 9 -19 had been covered already by the analysis of peptides 9 -17 and 18 -26. In the MS/MS spectrum, the predominant triply charged y14 ions and singly charged b2 ions indicated the presence of modifications on the N-terminal part (Fig. 6B) . SILAC quantitation was difficult to perform due to the low intensity of the peptide ions in S and G 2 /M phases. However, in addition to MS analysis, MS/MS analysis of the selection ion with the hypothetical parent masses could clearly confirm the absence of phosphorylated peptides in G 1 and S phases, indicating the exclusive presence of phosphopeptides in the mitotic phase. MS/MS spectra of peptides [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] (Fig. 7A and Supplemental Fig. 10, A and  B) . Mono-, di-, and trimethylation of Lys 27 and/or Lys 36 was identified in all three phases (Table IV) . In the MS analysis of the three variants, the ion intensities of methylated peptides in G 1 and S phases were similar, whereas those of mono-, di-, and trimethylated peptides increased and those of tetra-and pentamethylated peptides decreased in the G 2 /M phase. To confirm this change in methylation, quantitative MS analysis was performed using the SILAC approach. Increased ion intrimethylated peptides, respectively; and the ion at 455. 25 7A and Supplemental Fig. 10A ), and Ser 28 was found to be phosphorylated in addition to mono-, di-, and trimethylation on Lys 27 and/or Lys 36 (Table IV) . Also for histone H3.3 containing a Ser in position 31, phosphopeptides were detected exclusively in G 2 /M phase (Supplemental Fig. 10B ). Phosphorylation was identified, in addition to methylation on Lys 27 and/or Lys 36 , either at Ser 28 as previously found in H3.1 and H3.2 variants or at Ser 31 , the specific amino acid found only on the H3.3 sequence (Table IV and Supplemental Fig. 10C ). All MS/MS spectra of peptides 27-40 listed in Table IV (Table IV) and quantified by SILAC. No change in methylation was observed (Supplemental Fig. 11 ). All MS/MS spectra of peptides 73-83 listed in Table IV are shown in the supplemental data.
DISCUSSION
Elucidation of the modification patterns of histones that occur at a specific stage of the cell cycle has been a field of research for many years, and advances in analytical techniques have brought stepwise progress in these efforts. Here we present results of our approach, which introduces the combination of SILAC/mass spectrometry to the histone field. As an alternative method to quantify changes in histone modifications, LC-MS/MS has been suggested (31) . Recently Beck et al. (41) studied relative levels of acetylation and methylation under the influence of a histone deacetylase inhibitor (PXD101) by such an approach. This method based on nonisotope labeling quantitation had to address the issues of uneven ionization efficiencies, differences in sample loading, and discrepancies in chromatographic pattern by using internal standard peptides across LC-MS/MS experiments for data normalization. Although this method then becomes applicable to complex samples like tissues or blood, the SILAC approach has in many studies shown its accuracy, reliability, and ease of use in a cell-based system (34, 35) . Because our aim was solely the analysis of dynamic changes of histone modifications in HeLa cells, a combination of SILAC and nanospray MS analysis was the most direct and reliable strategy.
We aimed at providing an extensive analysis of the modifications that occur on the four core histones (H2A, H2B, H3, and H4) during the cell cycle. Our MS experiments allowed recognition of modifications (acetylation, methylation, or phosphorylation) that coexist on the same histone. For example, on H4, all combinations of acetylation, methylation, and phosphorylation were found. Peak intensities of MS spectra gave information about the extent of modification. Based on MS experiments with non-labeled cells, the modifications in the G 1 and S phases were largely identical for all core histones but underwent drastic changes during mitosis. This allowed us to limit the SILAC experiments to a comparison between S and G 2 /M phases. The SILAC data yielded quantitative information about relative changes of particular modified peptides (but not about the extent of modification). Cell cycle-dependent H2A and H2B modifications, which have not been investigated previously, showed a decrease in acetylation of H2A With respect to acetylation, it is generally accepted that changes in histone acetylation levels are associated with changes in chromatin structure (16, 17) . Thus, deacetylation leads to repression of transcription and is likely required for correct packaging of nucleosomes into metaphase chromosomes. In vitro, multiple acetylations on histone tails were shown to destabilize the chromatin fiber and to decondense chromatin fibers (42) . This phenomenon has recently been traced down to be due to the acetylation of histone H4 Lys 16 (43) . Also several studies with acetylation-specific antibodies have shown deacetylation of histones H3 and H4 in the mitotic phase (29, 44, 45) . In our study, we individually identified the G 2 /M phase decrease in acetylation of all acetylated sites for individual core histones (Fig. 8) . Our findings corroborate the findings made earlier exclusively by antibodies. In addition, we also quantified acetylated peptide ratios for H3 and H4.
Phosphorylation of histone proteins is known to be important for proper segregation and condensation of chromosomes during mitosis; mechanistic roles of phosphorylation in this process are beginning to evolve (8, 9, 46) . In our study, phosphorylation of histone H4 and multiple phosphorylation sites on the H3 variants were exclusively detected in G 2 /M phase. By contrast, phosphorylation of histone H2A did not change between G 1 , S, and G 2 /M phases. Largely in agreement with our results, Garcia et al. (47) ) . In their study, all N termini of the peptides were acylated by propionylation and all acidic residues were converted to methyl esters, and the samples were enriched for phosphopeptides using IMAC prior to tandem mass spectrometry. Neither derivatization nor enrichment steps were needed to identify phosphopeptides in our experiments. Other previous studies using phosphospecific antibodies have also found the phosphorylation sites on the H3 histones described above in mitotic phase (10, 11, 13, 14) . Phosphorylation on Thr 11 is an additional modification occurring at mitosis that has been found by immunoblotting and confocal immunofluorescence analyses (12) . Thr 11 phosphorylation was not detected with either our MS method or with that of Garcia et al. (47) . Because this modification is limited to centromeres it is likely that the amounts of Thr 11 phosphorylation are insufficient for detection by MS. Concerning histones H4 and H2A, a high level of phosphorylation on both Ser 1 residues could be observed by phosphospecific antibodies during mitosis, whereas a low level of phosphorylation was detected in asynchronized HeLa cells (15 (15) .
Methylation has been observed so far on six lysine residues of H3 and H4 histones. Recently methylation of H4 Lys 20 was described to increase specifically during mitosis, consistent with an increase in histone H4 Lys 20 methyltransferase (PRset7) activity during G 2 /M phase (48, 49) . Our findings corroborate the findings made earlier. In addition, we also quantified the increase of Lys 20 methylation to 2.5-fold for monomethylation and 1.5-fold for dimethylation. Here the high methylation on Lys 20 was found to be inversely correlated with deacetylation on H4 Lys 5 , Lys 8 , Lys 12 , and Lys 16 in mitotic phase indicating that these modifications have antagonizing functions. We can postulate that Lys 20 methylation serves as a recognition motif for the binding of chromatin-associated proteins that are involved in higher order chromatin structure during mitosis.
To date, there has been no study examining the cell cycle regulation of histone H3 Lys 27 and Lys 36 methylation levels. Here independently of phosphorylation, methylation of H3 Lys 27 and H3 Lys 36 were decreasing in the mitotic phase compared with S phase. The methylation of H3 on Lys 36 is known to be associated with transcriptional activity. Indeed the enzyme responsible for its modification has been shown to physically associate with RNA polymerase II during elongation (25) . Recently JHDM1 protein was identified to specifically demethylate histone H3 at Lys 36 in HeLa cells (50) . Thus the JHDM1 protein is probably activated in G 2 /M phase, therefore playing a specific role during mitosis. On the other hand, methylation of H3 Lys 27 was thought to be a marker for repressive chromatin (22, 23) . In our study, methylation on Lys 27 was unexpectedly decreasing in mitosis. It has been recently shown that the location of the Ser 10 residue in close proximity to Lys 9 enables the possibility that phosphorylation on Ser 10 influences Lys 9 methylation in G 2 /M phase (46, 51) .
Indeed phosphorylation on Ser 28 can also affect methylation on Lys 27 in G 2 /M phase.
For the first time, methylation on H3 Arg 2 was identified by mass spectrometry in G 1 , S, and G 2 /M phases of HeLa cells (19) . This site is known to be modified by the protein-arginine methyltransferase CARM1, which has been linked to active transcription (52) . Also methylation on H3 Lys 4 , known to be associated with gene activity (24) , was identified in the three phases. However, our method failed to indicate any change in methylation on Arg 2 and Lys 4 during the cell cycle. As previously discussed, Arg 2 and Lys 4 methylation may also be affected during mitosis when Thr 3 is phosphorylated.
Recently it has been found that phosphorylation of H3 Ser 10 by aurora B during mitosis required the previous deacetylation of H3 histones by histone deacetylase 3 (53, 54) . As for acetylation, changes in methylation occurring on residues nearby phosphorylation sites may also be required before kinase phosphorylation. Indeed methyltransferases or demethylases involved in regulation of methylation on H3 and H4 should also play important mechanistic roles in mitosis (55) .
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
